LCMT2 Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

LCMT2 Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 16 amino acids near the amino terminus of human TYW4.

  Source: Synthetic

  (Accession #: NP_055608)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: LCMT2
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-76585.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for LCMT2 Antibody Blocking Peptide

• EC 2.1.1.-
• FLJ51321
• KIAA0547tRNA-Wybutosine-synthesizing protein 4
• leucine carboxyl methyltransferase 2
• MGC9534
• p21WAF1/CIP1 promoter-interacting protein
• PPM2
• tRNA wybutosine-synthesizing protein 4 homolog
• tRNA yW-synthesizing protein 4 homolog
• TYW4tRNA-yW synthesizing protein 4

Background

LCMT2 is encoded by this intronless gene belongs to the highly variable methyltransferase superfamily. This gene is the inferred homolog of the Saccharomyces cerevisiae carboxymethyltransferase gene PPM2 that is essential for the synthesis of the hypermodified guanosine Wybutosine (yW).

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: LCMT2